Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Trazodone Hydrochloride Tablets USP, 50 mg, 100 ...

February 11, 2010 — The US Food and Drug Administration (FDA) has approved once-daily trazodone HCl extended-release tablets (Oleptro, Labopharm, Inc) for the treatment of major depressive disorder in ...

Oleptro available for major depressive disorder Labopharm and Angelini announced the launch of Oleptro (trazodone HCl extended-release tablets) for the treatment of major depressive disorder (MDD) in ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l72nrk/global_and) has announced the addition of the "Global and Chinese ...

The U.S. Food and Drug Administration proposed that the labels of all antidepressant medications warn of increased risks of suicidal thoughts and behavior for young adults, ages 18 to 24. Here is the ...